Psycheceutical Bioscience Liabilities 2024

Psycheceutical Bioscience Liabilities

2.42 M USD

Psycheceutical Bioscience Dividend yield

Ticker

BWVI

ISIN

US09609E1055

In 2024, Psycheceutical Bioscience's total liabilities amounted to 2.42 M USD, a 815.04% difference from the 264,380.01 USD total liabilities in the previous year.

Psycheceutical Bioscience Aktienanalyse

What does Psycheceutical Bioscience do?

Blue Water Ventures International Inc (BWVI) is a company specialized in the exploration of treasures on the seabed. The company's history dates back to 2005 when founder Keith Webb had the idea to search for lost treasures at sea. Since then, BWVI has become a leading company in the industry. BWVI's business model is based on treasure hunting at sea. The company uses state-of-the-art technologies to locate shipwrecks and other treasures on the ocean floor. Once a treasure is discovered, BWVI forms partnerships with other companies to recover and market the treasure. The profits from the sale of the treasure are divided between BWVI and its partners. BWVI also owns and operates its own online auction where antiques such as jewelry, historical coins, and artifacts are exhibited and sold. The auction is an important part of BWVI's business model and offers customers the opportunity to acquire unique treasures. The company has various divisions all focused on underwater treasure hunting. One division focuses on the exploration and search for sunken ships and artifacts. Another division focuses on the exploration of sites where potential treasures are suspected. BWVI utilizes state-of-the-art technologies such as sonar and magnetic sensors to locate underwater treasures. BWVI also offers services such as archiving and restoration of artifacts. The company collaborates with experts to ensure the best possible preservation and restoration of historical artifacts. BWVI's portfolio includes a variety of products and services. These include unique treasures such as jewels, gold and silver coins, ceramics, and other artifacts recovered from historical shipwrecks. Additionally, the company also offers merchandising items such as t-shirts, caps, and keychains featuring the BWVI logo. Recently, BWVI has also begun to explore other business areas. The company has partnered with a CBD product manufacturer and will be bringing CBD products to the market. Furthermore, BWVI has plans to enter the field of renewable energies, particularly tidal power plants. Overall, BWVI has undergone an impressive development in recent years. The company has established itself as a leading player in underwater treasure hunting and offers its customers a unique experience. With a strong portfolio of products and services and a clear vision for the future, BWVI is well-positioned to continue its success in the future. Psycheceutical Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Psycheceutical Bioscience's Liabilities

Psycheceutical Bioscience's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Psycheceutical Bioscience's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Psycheceutical Bioscience's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Psycheceutical Bioscience's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Psycheceutical Bioscience’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Psycheceutical Bioscience Stock

What is the level of liabilities of Psycheceutical Bioscience this year?

Psycheceutical Bioscience has a debt balance of 2.42 M USD this year.

What were the liabilities of Psycheceutical Bioscience compared to the previous year?

The liabilities of Psycheceutical Bioscience have increased by 815.04% increased compared to the previous year.

What are the consequences of high debt for investors of Psycheceutical Bioscience?

High liabilities can pose a risk for investors of Psycheceutical Bioscience, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Psycheceutical Bioscience?

Low liabilities mean that Psycheceutical Bioscience has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Psycheceutical Bioscience affect the company?

An increase in liabilities of Psycheceutical Bioscience can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Psycheceutical Bioscience affect the company?

A decrease in the liabilities of Psycheceutical Bioscience can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Psycheceutical Bioscience?

Some factors that can influence the liabilities of Psycheceutical Bioscience include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Psycheceutical Bioscience so important for investors?

The liabilities of Psycheceutical Bioscience are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Psycheceutical Bioscience take to modify the liabilities?

To change its liabilities, Psycheceutical Bioscience can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Psycheceutical Bioscience pay?

Over the past 12 months, Psycheceutical Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Psycheceutical Bioscience is expected to pay a dividend of 0 USD.

What is the dividend yield of Psycheceutical Bioscience?

The current dividend yield of Psycheceutical Bioscience is .

When does Psycheceutical Bioscience pay dividends?

Psycheceutical Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Psycheceutical Bioscience?

Psycheceutical Bioscience paid dividends every year for the past 0 years.

What is the dividend of Psycheceutical Bioscience?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Psycheceutical Bioscience located?

Psycheceutical Bioscience is assigned to the '-' sector.

Wann musste ich die Aktien von Psycheceutical Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Psycheceutical Bioscience from 6/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/3/2024.

When did Psycheceutical Bioscience pay the last dividend?

The last dividend was paid out on 6/3/2024.

What was the dividend of Psycheceutical Bioscience in the year 2023?

In the year 2023, Psycheceutical Bioscience distributed 0 USD as dividends.

In which currency does Psycheceutical Bioscience pay out the dividend?

The dividends of Psycheceutical Bioscience are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Psycheceutical Bioscience

Our stock analysis for Psycheceutical Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Psycheceutical Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.